Syntis Bio, Inc.
PrivateLast Round
Grant
Jul 1, 2025
Total Funding Raised
$38M
Momentum Score
25 /100
Company Overview
Syntis Bio, Inc. is a clinical-stage biopharmaceutical company developing oral therapies that harness the small intestine's biology for conditions like obesity, diabetes, and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Hardware Sales, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Syntis Bio, Inc. Comps
Public and private peers based on sector, stage, and business model.
Syntis Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2025 | ||||
| Series A | Jul 1, 2025 |
Syntis Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Cerity Partners Ventures | Series A |
| Cerberus Ventures | Series A |
| Mansueto Office | Series A |
| Woori Venture Partners Co., Ltd. | Series A |
| Colorcon Ventures | Series A |
| Safar Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2026
David Rosenbaum appointed as Chief Development Officer.
- Mar 3, 2026
Christo Shalish appointed as the new Chief Business Officer.
Syntis Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Syntis Bio, Inc.'s valuation, stock price, and market status.
